Cargando…
Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease
This study examined whether longitudinal MRI trajectories in medial temporal lobe (MTL) brain regions differed among groups of cognitively normal individuals defined by their cerebrospinal fluid (CSF) levels when they were first enrolled (N = 207; mean clinical follow-up = 13.3 years (max = 20 years...
Autores principales: | Pettigrew, Corinne, Soldan, Anja, Sloane, Kelly, Cai, Qing, Wang, Jiangxia, Wang, Mei-Cheng, Moghekar, Abhay, Miller, Michael I., Albert, Marilyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577409/ https://www.ncbi.nlm.nih.gov/pubmed/28879085 http://dx.doi.org/10.1016/j.nicl.2017.08.022 |
Ejemplares similares
-
Cortical thickness in relation to clinical symptom onset in preclinical AD
por: Pettigrew, Corinne, et al.
Publicado: (2016) -
Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer’s Disease
por: Younes, Laurent, et al.
Publicado: (2019) -
Longitudinal CSF Alzheimer's disease biomarker changes from middle age to late adulthood
por: Pettigrew, Corinne, et al.
Publicado: (2022) -
Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD
por: Gross, Alden L., et al.
Publicado: (2019) -
Medial temporal lobe atrophy and posterior atrophy scales normative values
por: Cotta Ramusino, Matteo, et al.
Publicado: (2019)